Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Drye

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Geriatric Psychiatry|July 31, 2010
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?Lea T Drye, Barbara K Martin, Constantine E Frangakis, et al.
Investigative Ophthalmology & Visual Science|January 17, 2012
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trialKevin D Frick, Lea T Drye, John H Kempen, et al.
Journal of Geriatric Psychiatry and Neurology|August 26, 2015
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic InfluencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 4, 2012
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer diseaseCynthia A Munro, Crystal Flynn Longmire, Lea T Drye, et al.
British Journal of Clinical Pharmacology|May 5, 2016
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitationThang Ho, Bruce G Pollock, Benoit H Mulsant, et al.
Parkinsonism & Related Disorders|August 26, 2015
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's diseaseMallory L Hacker, James Tonascia, Maxim Turchan, et al.
American Journal of Alzheimer'S Disease and Other Dementias|July 5, 2018
Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's DiseaseYe Tao, Matthew E Peters, Lea T Drye, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 10, 2013
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2Crystal V Flynn Longmire, Lea T Drye, Constantine E Frangakis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2019
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trialStephan Ehrhardt, Anton P Porsteinsson, Cynthia A Munro, et al.
Journal of Geriatric Psychiatry and Neurology|January 10, 2012
Sertraline for the treatment of depression in Alzheimer disease: genetic influencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Geriatric Psychiatry|July 31, 2010
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?Lea T Drye, Barbara K Martin, Constantine E Frangakis, et al.
Investigative Ophthalmology & Visual Science|January 17, 2012
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trialKevin D Frick, Lea T Drye, John H Kempen, et al.
Journal of Geriatric Psychiatry and Neurology|August 26, 2015
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic InfluencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 4, 2012
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer diseaseCynthia A Munro, Crystal Flynn Longmire, Lea T Drye, et al.
British Journal of Clinical Pharmacology|May 5, 2016
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitationThang Ho, Bruce G Pollock, Benoit H Mulsant, et al.
Parkinsonism & Related Disorders|August 26, 2015
Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's diseaseMallory L Hacker, James Tonascia, Maxim Turchan, et al.
American Journal of Alzheimer'S Disease and Other Dementias|July 5, 2018
Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's DiseaseYe Tao, Matthew E Peters, Lea T Drye, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 10, 2013
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2Crystal V Flynn Longmire, Lea T Drye, Constantine E Frangakis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2019
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trialStephan Ehrhardt, Anton P Porsteinsson, Cynthia A Munro, et al.
Journal of Geriatric Psychiatry and Neurology|January 10, 2012
Sertraline for the treatment of depression in Alzheimer disease: genetic influencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
Pageof 5